Your browser version may not work well with NCBI's Web applications. More information here...
1: J Clin Invest. 1997 May 15;99(10):2375-85.
Related Articles, Links
Click here to read Click here to read
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.

Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE.

Department of Pathology, Emory University, Atlanta, Georgia 30322, USA.

Angiotensin-converting enzyme (ACE) generates the vasoconstrictor angiotensin II, which plays a critical role in maintenance of blood pressure in mammals. Although significant ACE activity is found in plasma, the majority of the enzyme is bound to tissues such as the vascular endothelium. We used targeted homologous recombination to create mice expressing a form of ACE that lacks the COOH-terminal half of the molecule. This modified ACE protein is catalytically active but entirely secreted from cells. Mice that express only this modified ACE have significant plasma ACE activity but no tissue-bound enzyme. These animals have low blood pressure, renal vascular thickening, and a urine concentrating defect. The phenotype is very similar to that of completely ACE-deficient mice previously reported, except that the renal pathology is less severe. These studies strongly support the concept that the tissue-bound ACE is essential to the control of blood pressure and the structure and function of the kidney.

Publication Types:
PMID: 9153279 [PubMed - indexed for MEDLINE]

PMCID: PMC508076